According to research by SNS Insider, the liver cancer treatment market is experiencing significant growth due to a combination of factors including increasing incidence, advances in diagnosis and treatment, government support, and an aging population.
Pune, October 25, 2023 (GLOBE NEWSWIRE) — “SNS Insider reports that Liver cancer treatment market The value in 2022 was US$2,923.58 million and is expected to reach US$12,910.02 million by 2030, growing at a compound annual growth rate (CAGR) of 20.4% during the forecast period from 2023 to 2030. “
market Overview
Liver cancer treatment refers to a variety of medical interventions and treatment strategies aimed at controlling and potentially curing liver cancer, also known as hepatocellular carcinoma (HCC) or liver cancer. For early-stage liver cancer, surgical resection is usually the first option. This involves removing the tumor and part of the surrounding healthy tissue. The cancer is considered cured if it has not spread widely. These minimally invasive procedures use heat or cold to destroy cancerous tissue. Techniques include radiofrequency ablation, microwave ablation, and cryoablation. They are often used to treat small tumors or when surgery is not possible. Treatment options depend on the individual patient’s circumstances, including the stage of the cancer, overall health, and the presence of underlying liver disease. Often, a combination of treatments is used to treat liver cancer.
Market analysis
The liver cancer treatment market is influenced by several growth drivers that continue to shape the industry. In recent years, the incidence of liver cancer has been on the rise due to a variety of factors including lifestyle choices, increased alcohol consumption, hepatitis B and C infections, and the prevalence of non-alcoholic fatty liver disease. This higher incidence drives the need for effective treatments. The development of novel treatments, including targeted therapies, immunotherapy, and precision medicine, is significantly expanding patient options. These innovative approaches are improving survival rates and quality of life. Governmental organizations and health agencies around the world are recognizing the growing burden of liver cancer and are providing funding and support for research, diagnosis and treatment. This financial support facilitates the development of treatments. The aging of the global population leads to a higher risk of liver cancer. As the elderly population grows, the need for liver cancer treatments is expected to increase.
Get Liver Cancer Treatment Market Sample Report@ https://www.snsinsider.com/sample-request/3215
Key company profiles listed in this report include:
Key players include ImClone Systems Inc., Alnylam Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Onyx Pharmaceuticals Inc., ArQule Inc., Pfizer Inc., Celsion Corp., Jennere Biotherapeutics Inc., 4SC AG, Bayer Schering Pharma AG and other players.
Liver Cancer Treatment Market Report Scope:
|
Report properties |
detail |
|
Market size in 2022 |
US$2.92358 billion |
|
Market size in 2030 |
12910.02 million US dollars |
|
CAGR |
The compound annual growth rate from 2023 to 2030 is 20.4% |
|
base year |
2022 |
|
forecast period |
2023-2030 |
|
historical data |
2019-2021 |
|
Main area coverage |
North America (United States, Canada, Mexico), Europe (Eastern Europe (Poland, Romania, Hungary, Turkey, Rest of Eastern Europe), Western Europe) Germany, France, United Kingdom, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe) . Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East and Africa (Middle East (UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East)), Africa (Nigeria, South Africa, Other parts of Africa), Latin America (Brazil, Argentina, Colombia, other parts of Latin America) |
Key Points of Liver Cancer Treatment Market Study
-
The field of immunotherapy has become a dominant force in the market. One of the main advantages of immunotherapy is its precision. Unlike traditional therapies, which damage healthy cells as well as cancer cells, immunotherapy specifically targets malignant tumors. This reduces side effects and improves the patient’s overall quality of life during treatment.
-
While immunotherapy may be revolutionizing the liver cancer treatment market, the role of retail pharmacies cannot be ignored. Retail pharmacies are an important link between patients and the medications prescribed by their healthcare providers. They play a key role in ensuring liver cancer patients have timely and effective access to prescribed medications, and play a key role in their treatment.
recent developments
-
charles river A ground-breaking partnership was recently established to advance the development of gene therapies specifically targeting this life-threatening disease. The collaboration builds on Charles River’s extensive expertise in drug discovery and preclinical research, which will be synergistically combined with the collaborative experts’ innovative gene therapy approaches.
-
this University of Southern California (USC) A promising collaboration has been established with Auransa, a biopharmaceutical company known for its pioneering work in cancer treatments. This joint effort marks the launch of a Phase 1 clinical trial of a breakthrough drug targeting liver cancer.
If you have any specific questions about the Liver Cancer Treatment Market or require any customized research, ask now@ https://www.snsinsider.com/enquiry/3215
Market Dynamic Analysis
The liver cancer treatment market is currently undergoing dynamic changes driven by multiple factors. Among drivers, rising rates of liver cancer, particularly in areas with high rates of chronic hepatitis B and hepatitis C infection, are stimulating the need for innovative treatment options. Advances in medical research and technology have also led to the development of new therapies such as targeted molecular drugs and immunotherapy, bringing new hope to patients. However, this market faces several limitations and challenges. Early diagnosis and effective treatment options remain limited, often leading to late detection and poor outcomes. This situation is further exacerbated by limited access to healthcare in some areas. Additionally, the high cost of advanced therapies, including immunotherapy, creates financial challenges for patients and the healthcare system. Additionally, the market faces a potential threat from the rising incidence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as these diseases may progress to liver cancer over time. The changing regulatory environment (which governs drug approval and reimbursement policies) also creates a complex environment for market participants.
Liver cancer treatment market segmentation:
By treatment type
-
Immunotherapy
-
Targeted drug therapy
-
Chemotherapy
By distribution channel
-
retail pharmacy
-
hospital pharmacy
-
online pharmacy
Major regional developments
In North America, the liver cancer treatments market is driven by factors such as high prevalence of risk factors such as obesity, alcohol consumption, and viral hepatitis. The region has advanced medical infrastructure and a strong pharmaceutical industry, promoting the development and adoption of new treatments. The burden of liver cancer is high in Europe, especially in Eastern and Southern European countries, due to high rates of hepatitis B and hepatitis C infection. Access to health care varies across the region, with Western Europe offering better health care infrastructure. The Asia-Pacific region accounts for a significant proportion of liver cancer cases, which is mainly attributed to the high prevalence of hepatitis B and C as well as dietary and lifestyle factors.
Impact of Economic Recession on Liver Cancer Treatment Market Growth
The impact of an economic recession on the liver cancer treatment market may vary across regions and countries, depending on their healthcare systems, economic stability, and healthcare policies. Physicians and health care systems may reconsider treatments during a recession, choosing more cost-effective treatments or focusing on strategies that maximize the use of available resources. Recession-induced restrictions on in-person care may accelerate the adoption of telemedicine and remote monitoring technologies. This could improve access to care and reduce costs, making it a potential silver lining in economically difficult times. As health care systems look for ways to reduce costs, there may be a greater emphasis on preventive measures and early detection, which will ultimately benefit liver cancer patients.
Purchase the PDF version of “Liver Cancer Treatment Market Report 2023-2030” for corporate users@ https://www.snsinsider.com/checkout/3215
Table of contents
1. Introduction
2. Research methods
3. Market dynamics
4. Impact analysis
5. Value chain analysis
6. Porter’s Five Forces Model
7.PEST analysis
8. Liver Cancer Treatment Market Segmentation by Treatment Type
9. Liver Cancer Treatment Market Segmentation by Distribution Channel
10. Regional analysis
11. Company Profile
12. Competitive Landscape
13. Use cases and best practices
14. Conclusion
Access full report details@ https://www.snsinsider.com/reports/liver-cancer-therapeutics-market-3215
(For more information or for any custom research, please email info@snsinsider.com)
about Us:
Social Network Insider It is one of the leading market research and consulting organizations that dominates the global market research industry. Our company’s goal is to provide clients with the knowledge they need to operate in an ever-changing environment. To provide you with the latest, accurate market data, consumer insights and opinions so you can make decisions with confidence, we use a variety of techniques including surveys, video lectures and focus groups around the world.
CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) Website: https://www.snsinsider.com/
